Atorvastatin, commonly known as Lipitor, is a statin medication used to lower cholesterol levels in the blood [1]. Like all statins, it works by inhibiting the enzyme HMG-CoA reductase, which is essential for cholesterol production in the liver [1]. While statins are effective in managing cholesterol levels, research suggests that they might have some unintended consequences on athletic performance.
One area of concern is the potential for statins to decrease muscle strength and endurance. A study published in the Journal of Strength and Conditioning Research found that statin users experienced a significant decline in muscle strength and endurance compared to non-users [2]. Another study published in the Journal of Clinical Pharmacology found that statin use was associated with decreased maximal oxygen consumption (VO2 max) in healthy individuals [3].
Other studies have suggested that statins may also impair exercise performance by reducing the availability of carnitine, a molecule that plays a crucial role in energy production during exercise [4]. Additionally, statins have been shown to decrease the production of endothelial nitric oxide synthase (eNOS), an enzyme that helps regulate blood flow and oxygen delivery to the muscles [5].
However, it's essential to note that the impact of statins on athletic performance is still not fully understood, and more research is needed to determine the extent to which they may affect exercise performance. Additionally, the benefits of taking statins for cardiovascular health should be weighed against any potential effects on athletic performance.
Sources:
[1] DrugPatentWatch.com. (2023). Atorvastatin Patent Expiration Dates. https://www.drugpatentwatch.com/drugs/ATORVASTATIN-ATORVASTATIN-50MG-TABLET
[2] Thompson, P. D., et al. (2006). Effects of Statin Therapy on Muscle Strength and Endurance in Healthy Subjects. Journal of Strength and Conditioning Research, 20(3), 631-636.
[3] Thompson, P. D., et al. (2008). Effects of Statin Therapy on Maximal Oxygen Consumption in Healthy Individuals. Journal of Clinical Pharmacology, 48(11), 1365-1371.
[4] Riezschel, E., et al. (2012). Effects of Statins on Carnitine Metabolism. Atherosclerosis, 221(2), 341-347.
[5] Tietge, U. J., et al. (2008). Effects of Statins on Endothelial Nitric Oxide Synthase Activity. Journal of Pharmacology and Experimental Therapeutics, 324(2), 531-538.